Methadone, Buprenorphine and the Community Live (2022/2023)

This course meets the training requirements (minimum every five years) for pharmacists dispensing methadone.  It also meets the training requirements for those pharmacists who are not required to take the CAMH ODT Core course.





Learners will attend a live presentation of the course on Sunday, February 26, 2023, at the OPA office at 155 University Avenue, Toronto. This program is expected to run from approximately 9 am to 5 pm. Complimentary continental breakfast, lunch and coffee breaks will be provided. Learners will be provided with more information in early February 2023.

Successful completion of this course qualifies as an approved training course as part of their training update for pharmacists dispensing methadone. Updates are required at minimum every five years as indicated in the Ontario College of Pharmacists’ Opioid Policy.

Please note that this course does not replace the CAMH Opioid Use Disorder (OUDT) course, which Designated Managers and pharmacists are required to complete to dispense methadone as outlined in the Ontario College of Pharmacists’ Opioid Policy.

Looking for Methadone, Buprenorphine and the Community Online? Click here for more information.

This course is supported by funding from the Mental Health and Addiction Centre of Excellence of Ontario Health.

Learning objectives:

By the end of this course, you should be able to:

Opioid Agonist Therapy

  • Identify those at risk for opioid use disorder
  • Discuss treatment options for OUD
  • Review safe prescribing and dispensing of opioid agonist therapy
  • Outline the components of a comprehensive OAT program
  • Discuss strategies for interprofessional collaboration and to reduce stigma


Opioid Agonist Therapy: Special Topics

  • Identify options for pain control for patients on Opioid Agonist Therapies
  • Discuss co-prescribing of benzodiazepines with OAT
  • Review management of pregnant patients with Opioid Use Disorder
  • Explore the role of the pharmacist in harm reduction


Policies Guiding Methadone Dispensing in Ontario

  • Identify College of Physicians and Surgeons of Ontario (CPSO) and Ontario College of Pharmacists (OCP) policies that pharmacists should refer to when dispensing methadone in Ontario.
  • Review current OCP Opioid Policy – formerly Methadone Maintenance Treatment (MMT) and Dispensing Policy
  • Review labelling, documentation, and staff training requirements for dispensing methadone
  • List required and additional references and resources for dispensing methadone
  • Review buprenorphine/naloxone dispensing including list of references and resources briefly


Operationalizing Methadone Dispensing Policies in Ontario

  • Review and describe OCP Opioid Policy for dispensing methadone in Ontario
  • Describe how OCP Opioid Policy and best practices can be implemented in your pharmacy settings
  • Find practical resources and tools to work and run OAMT dispensing pharmacies


Destigmatizing Opioid Use Disorder

  • Describe the impact of stigma on patients with opioid use disorder
  • Communicate effectively through the use of non-stigmatizing language when dealing with sensitive or discrete issues


Interview with a Person with Lived Experience

  • Consider the impact of stigma when dealing with patients who use opioids
  • Learn about stigma from a person with lived experience
  • Reflect on your role in reducing stigma in your practice

Course outline:

  • I. In-person session
  • II. Post-session final exam
    Final multiple-choice exam (1 hour)

Course at a glance:

  • 9 hours to complete
  • 5.5 CEUs
  • Course Expiration Date: October 21, 2023
  • Online/In Person
  • Accreditation: 8003-2021-3329-L-P
  • Completion requirement: Attend the in-person session, complete the multiple-choice exam with a score of 70 per cent or higher (two attempts), and complete the program evaluation.

Who should take this course:

This course is open and applicable to all pharmacy professionals including students and pharmacy technicians. Any pharmacy professionals who are interested in or currently dispensing methadone are welcome to attend. 

Development Team:

  • Juno Kim, RPh (PharmD)
  • Mary Nelson, RPh (BScPhm)
  • Cassandra Huck, RPh (BScPhm)
  • Mohammad-Usman Imran, RPh (BScPhm)
  • Rose Fitzgerald, RPh (BScPhm) 
  • Destiny Anderson, RPhT